An Alaska psychedelics task force is recommending that the state move forward with plans to provide regulated access to psychedelics if the federal Food and Drug Administration (FDA) authorizes the medical use of substances like psilocybin and MDMA.
After about a year of work studying the issue under a law enacted in 2024, the Alaska Legislative Task Force for the Regulation of Psychedelic Medicines on Thursday unveiled its findings and recommendations.
“Alaska has some of the highest rates in the nation of domestic violence survivors and combat veterans who experience PTSD, and many of these Alaskans continue to struggle with traditional treatments,” Sen. Forrest Dunbar (D), co-chair of the task force, said in a press release.
“Our approach to these new medical therapies needs to be properly and independently evaluated to ensure that if the legislature were to make policy changes, we do so with empirical data in a properly controlled environment,” the senator said.
The panel’s report lists a series of findings, informed by a review of scientific literature and expert testimony.That includes findings that certain psychedelics do, in fact, possess “potential therapeutic uses,” and “there is particular focus on use of these therapies for veterans, survivors of assault
Read full article on Marijuana Moment
